Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Reksa Dana Indeks Majoris Pefindo I-Grade ETF Indonesia (XMIG) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Reksa Dana Indeks Majoris Pefindo I-Grade ETF IndonesiaTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Reksa Dana Indeks Majoris Pefindo I-Grade ETF Indonesia — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 319B, 50.8K 24h volume), while Reksa Dana Indeks Majoris Pefindo I-Grade ETF Indonesia trades at Rp163 (market cap 3.26B, 7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 97.9× Reksa Dana Indeks Majoris Pefindo I-Grade ETF Indonesia's market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (50.8K versus 7K). Which is the better fit depends on your goals.

DGNSXMIG
Market Cap
319B3.26B
Volume
50.8K7K
Lot
50870
Turnover
11.61M1M
Average Price
228.47143.24
Value
11.61M1M
Indicative Equilibrium Price
232
Indicative Equilibrium Volume
200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Reksa Dana Indeks Majoris Pefindo I-Grade ETF Indonesia

Read more on XMIG